Literature DB >> 7851027

IgG-associated primary glomerulonephritis in children.

N Yoshikawa1, K Iijima, M Shimomura, H Nakamura, H Ito.   

Abstract

Ten children with IgG-associated primary diffuse mesangial proliferative glomerulonephritis are presented. All cases showed diffuse global IgG deposits in the mesangium. IgG was the sole immunoglobulin deposited in the mesangium in 8 patients and was the predominant immunoglobulin in 2. C3 was also present in 8 patients. Light microscopy revealed variable diffuse and global mesangial proliferation in all cases, with additional focal segmental glomerular sclerosis in one. On electron microscopy, electron-dense deposits in the mesangium were identified in all patients. Clinically, 4 patients presented with the steroid-resistant nephrotic syndrome, and 6 had proteinuria and hematuria. At the latest follow-up, renal function was normal in all patients, 6 showed clinical remission and 4 had slight proteinuria and/or hematuria. These data suggest that there is a clinicopathologic entity, IgG-associated glomerulonephritis, characterized by diffuse mesangial proliferation, predominant mesangial IgG deposition, variable clinical presentation, and a relatively benign course.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7851027

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  3 in total

1.  C1q nephropathy: features at presentation and outcome.

Authors:  Keith K Lau; Lillian W Gaber; Noel M Delos Santos; Robert J Wyatt
Journal:  Pediatr Nephrol       Date:  2005-04-13       Impact factor: 3.714

2.  A possible role of classical complement pathway activation in the pathogenesis of immunoglobulin G nephropathy: a case report.

Authors:  Momoko Arai; Akiko Mii; Akio Hirama; Tomohiro Kaneko; Tetsuya Kashiwagi; Akira Shimizu; Yukinao Sakai
Journal:  CEN Case Rep       Date:  2022-06-16

3.  Renal Tubular Complement 3 Deposition in Children with Primary Nephrotic Syndrome.

Authors:  Fengying Wang; Xiaozhong Li; Xueming Zhu; Qing Chen; Lu Jiang; Ziqiang Zhu
Journal:  Biomed Res Int       Date:  2018-05-30       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.